Insulet Reports Q3 Profit Surge, Revenue Up 30% YoY.

Insulet Corporation reported a Q3 net income of $87.6 million, up from $77.5 million YoY. Adjusted net income was $87.8 million, and revenues reached $706.3 million, up from $543.9 million last year. The company's CEO, Ashley McEvoy, attributed the strong results to the success of Omnipod 5 and the company's engagement with the diabetes community.